MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
HIV and tuberculosis co-infection: A 7 year retrospective cohort study Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015
A retrospective analysis of outcome of Isoniazide preventive therapy in adults living with HIV in Penang, Malaysia Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India; an interim analysis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Effectiveness of mandatory treatment for tuberculosis - An observational registry study Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Co-morbid conditions associated with tuberculosis (TB): Results from a 1-day, point-prevalence study in 204,912 physician diagnosed patients from 880 cities and towns in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Prospective study analysing prevalence of XDR TB in Mumbai, India Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Clinical and epidemiological data in Tuberculosis (TB) - AIDS patients Source: Eur Respir J 2005; 26: Suppl. 49, 426s Year: 2005
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015